about
Ultrasound in juvenile idiopathic arthritisEULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation.Relative responsiveness of condition specific and generic health status measures in juvenile idiopathic arthritisDevelopment and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis.A Patient-Specific Foot Model for the Estimate of Ankle Joint Forces in Patients with Juvenile Idiopathic Arthritis.A circulating reservoir of pathogenic-like CD4+ T cells shares a genetic and phenotypic signature with the inflamed synovial micro-environment.Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanerceptTCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis.Advances and challenges in imaging in juvenile idiopathic arthritis.Towards a role of ultrasound in children with juvenile idiopathic arthritis.The OMERACT Ultrasound Working Group 10 Years On: Update at OMERACT 12.Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial.Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis.Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.ProNGF-p75NTR axis plays a proinflammatory role in inflamed joints: a novel pathogenic mechanism in chronic arthritis.Current state of musculoskeletal ultrasound in paediatric rheumatology: results of an international survey.Development and validation of a composite disease activity score for juvenile idiopathic arthritis.Factors affecting survival in juvenile systemic sclerosis.Prognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritis.Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis.Imaging in juvenile idiopathic arthritis - international initiatives and ongoing work.Preliminary Definitions for the Sonographic Features of Synovitis in Children.A new short and simple health-related quality of life measurement for paediatric rheumatic diseases: initial validation in juvenile idiopathic arthritis.Switched Memory B Cells Are Increased In Oligoarticular And Polyarticular Juvenile Idiopathic Arthritis And Their Change Over Time Is Related To Response To TNF Inhibitors.Toward Standardized Musculoskeletal Ultrasound in Pediatric Rheumatology: Normal Age-Related Ultrasound Findings.A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile Arthritis Multidimensional Assessment Report.Development and initial validation of a radiographic scoring system for the hip in juvenile idiopathic arthritis.Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis.Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sampleUltrasound-detected synovial abnormalities are frequent in clinically inactive juvenile idiopathic arthritis, but do not predict a flare of synovitisComparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritisPhagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative studyDefinitions for the Sonographic Features of Joints in Healthy ChildrenAntinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritisAchievement of a State of Inactive Disease at Least Once in the First 5 Years Predicts Better Outcome of Patients with Polyarticular Juvenile Idiopathic ArthritisThe magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritisVisceral leishmaniasis as a cause of unexplained fever and cytopenia in systemic lupus erythematosusUse of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritisCorrelation between juvenile idiopathic arthritis activity and damage measures in early, advanced, and longstanding disease
P50
Q26745505-957E37C9-11A5-4DC8-8376-5810B71955C8Q34109962-0227C25D-DB81-4DD0-B81D-30EC1CBE5206Q35555214-0D2D253C-867B-46F2-A100-8497A92FDBFEQ36178472-1C75265F-7D85-43AE-8F48-C52E818E0939Q36403381-91C99898-8C77-47BC-959E-4924491A9F0DQ36577387-73D5AE8D-864F-494E-8EBB-71CA46CAE709Q37518319-26D927AB-F143-4EF6-8FB2-E0BDA5344734Q37616990-079E5D9F-8CB3-4D8A-91F0-E9E9C39D6201Q37997306-CA1239EF-224C-4299-B01A-384EFFD3D829Q38059101-982B745C-3338-4054-A826-DD999BA19ED9Q38379378-08D9FFAD-D0D3-44F5-AE70-A4308F511FFFQ38761381-F6C20BC6-D07B-4924-91CA-D4CFF855856BQ39761819-16B882C4-064A-4DD8-ADB8-94BCFC5D57D1Q40064593-D71A6BC8-7BB4-49A6-8073-E3B02D9AA6CBQ41068374-BEBE788F-C0FB-4A45-A3D4-9340FFAEC258Q41687143-1A3DEBD1-9296-4B33-B045-DCD1266A6099Q42628842-75B4DAF9-7A90-419C-B42B-DF14234C89E0Q46030916-2FD31B71-84F6-4F6F-A56D-71CA8A2033CEQ46317363-91D484C6-6A7D-4548-BAA1-FDCF23707B31Q47321706-659C4E92-AF66-46A6-A37C-54ACAC05B234Q48264478-9593260D-29FC-47F3-9222-A2D0FC18FC9DQ48518130-4198A807-3B84-413A-AA7F-9E57057667BAQ48772188-6C1BD120-8D27-4384-AB0B-9EEB71C298BAQ48853317-00F066AE-FCC9-4142-87D5-C4E1CFDA7787Q50112220-1D09AB29-4036-4225-95B0-58F739E12172Q51831708-64063C39-231F-45FE-A2B1-1001C180AEC9Q53047736-80FD7648-6E98-484B-978D-23A8182B0D22Q53063302-0CE634F3-D43A-4FE9-8716-4165B4B0DBA9Q54442285-4C1E9F59-C19B-4091-A8AF-FCD3E1A1F20DQ56783328-EDFEBC18-3214-46F3-B4D6-DADAC082A8F6Q57786184-C5CEB4CA-7975-44F4-AD46-2CFA91DC55F8Q57786256-66579D40-30BB-4427-8F02-3F2F0981FBD9Q58429085-71912193-0AB4-4959-A413-E34F0D99F101Q61633701-B0FFD2B4-002B-48E3-81CA-98355F526989Q62741431-6F38AF32-DDFC-4A48-9268-445A50A463E1Q62741443-AC846032-F887-4ED9-A69C-0B7BBC9CF968Q62741468-8907DFA6-1AA3-415D-82EE-6914E34F653FQ77935394-D10E7043-D97C-4B88-899D-2B9C9818AA9FQ79169611-10067816-6E37-4AC4-AD71-B3CC6C96AB28Q79398048-A4D28F5E-EE1C-434A-8081-BB3E50749DEA
P50
description
researcher ORCID ID = 0000-0002-5714-1141
@en
wetenschapper
@nl
name
Silvia Magni Manzoni
@ast
Silvia Magni Manzoni
@en
Silvia Magni Manzoni
@es
Silvia Magni Manzoni
@nl
type
label
Silvia Magni Manzoni
@ast
Silvia Magni Manzoni
@en
Silvia Magni Manzoni
@es
Silvia Magni Manzoni
@nl
prefLabel
Silvia Magni Manzoni
@ast
Silvia Magni Manzoni
@en
Silvia Magni Manzoni
@es
Silvia Magni Manzoni
@nl
P1153
6602281787
P21
P31
P496
0000-0002-5714-1141